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cases with severe Motor and 
intellectual Disabilities showing 
sudden Unexplained Death
Masaharu Hayashi* and Hiroshi Sakuma
Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
It is known that patients with severe motor and intellectual disabilities (SMID) showed 
sudden unexplained death (SUD), in which autopsy failed to identify causes of death. 
Although the involvement of brainstem dysfunction is speculated, the detailed neu-
ropathological analysis still remains to be performed. In order to clarify pathogenesis, 
we investigated the brainstem functions in autopsy cases of SMID showing SUD. We 
immunohistochemically examined expressions of tyrosine hydroxylase, tryptophan 
hydroxylase, substance P, methionine-enkephalin, and c-fos in the serial sections of 
the midbrain, pons, and medulla oblongata in eight SUD cases and seven controls, 
having neither unexplained death nor pathological changes in the brain. Expressions of 
tyrosine hydroxylase and tryptophan hydroxylase were reduced in two of eight cases, 
and those of substance P and/or methionine-enkephalin were augmented in the pons 
and medulla oblongata in seven of eight cases, including the aforementioned two cases, 
when compared with those in controls. The hypoglossal nucleus and/or the dorsal 
vagal nucleus demonstrated increased neuronal immunoreactivity for c-fos in seven of 
eight cases, although there was no neuronal loss or gliosis in both the nuclei. Controls 
rarely showed immunoreactivity for c-fos in the medulla oblongata. These data suggest 
the possible involvement of brainstem dysfunction in SUD in patients with SMID, and 
consecutive neurophysiological evaluation of brainstem functions, such as all-night 
polysomnography and blink reflex, may be useful for the prevention of SUD, because 
some parameters in the neurophysiological examination are known to be related to the 
brainstem catecholamine neurons and the spinal tract nucleus of trigeminal nerve.
Keywords: severe motor and intellectual disabilities, sudden unexplained death, brainstem, immunohistochemistry, 
catecholamine, substance P, c-fos
inTrODUcTiOn
Severe motor and intellectual disabilities (SMID) describe a heterogeneous group of disorders with 
severe physical disabilities and profound mental retardation (1, 2). Patients with SMID are frequently 
complicated with various neurological disorders and respiratory problems, such as upper airway 
obstruction, aspiration, and central apnea (3–5), in addition to circulatory disturbances. In patients 
with SMID, it is known that sudden unexplained death (SUD) accounts for 5% of cause of death (6), 
and definite causes are not identified even after autopsy in some cases. The involvement of brainstem 
TaBle 1 | summary of clinical and pathological findings.
no. age  
(year)/sex
Brain  
disorders
cause of  
death
resuscitation 
time (h)
Postmortem 
time (h)
Brain  
weight (g)
increase of 
goblet cells
controls
1 7/male (−) Sepsis nd nd (−)
2 9/male (−) Sepsis nd nd (−)
3 10/male (−) Leukemia 4 nd (−)
4 22/male (−) DIC nd nd (−)
5 29/male (−) Heart failure nd nd (−)
6 38/male (−) Leukemia nd nd (−)
7 55/male (−) Pulmonary cancer 5 1400 (−)
sudden unexplained death
1 6/male Kernicterus 2 3 1331 1+
2 9/male Schizencephaly 10 2 499 1+
3 13/male Perinatal HIE 3 2 635 1+
4 20/male Perinatal HIE 0.5 3 580 1+
5 23/female Micro syndrome 1 7.5 260 (−)
6 29/female Kernicterus 0.5 2 1437 1+
7 36/male Postnatal HIE 2 6 578 1+
8 47/male Encephalopathy 3 4 1348 (−)
The degree of goblet cell change was graded by visual inspection as absence (−) or presence 1+. DIC, disseminated intravascular coagulation; HIE, hypoxic ischemic 
encephalopathy; nd, not determined.
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dysfunction is speculated in sudden infant death syndrome (SIDS) 
(7–9), and disturbances of brainstem catecholamine neurons 
were involved in sudden death in developmental brain disorders, 
such as SIDS and Fukuyama-type congenital muscular dystrophy 
(FCMD) (10, 11). The brainstem expression of substance P was 
augmented in the spinal tract nucleus of trigeminal nerve in SIDS 
victims and cases of FCMD showing SUD (10, 12). In addition, 
the altered expression of proto-oncogene c-fos, a marker of early 
neuronal activation subsequent to noxious stimulation, was 
observed in sudden death in neurological disorders (12–14). 
Herein, we performed the comprehensive immunohistochemis-
try on the brainstem lesions in autopsy cases, in order to clarify 
the pathogenesis of SUD in patients with SMID, and discussed 
the possibility of monitoring SUD using neurophysiological 
examination.
PaTienTs anD MeThODs
The clinical subjects comprised eight cases of SMID showing SUD 
(the SUD cases) between 1968 and 2001 at Tokyo Metropolitan 
Fuchu Medical Center for the Disabled and Tokyo Metropolitan 
Neurological Hospital and seven controls, aged from 7 to 55 years, 
showing neither SUD nor pathological changes in the central 
nervous system (Table 1). The family of each subject provided 
informed consent to the detailed neuropathological analysis. 
The brains were fixed in a buffered formalin solution, and each 
formalin-fixed brain was cut coronary, embedded in paraffin. We 
examined the cerebral cortex and white matters, basal ganglia, 
thalamus, cerebellum, brainstem, and spinal cord by routine 
histochemical staining and failed to find neither neuronal loss 
nor gliosis in each region. Considering the possibility of func-
tional lesions in the brainstem, which have been pointed out in 
SIDS and/or FCMD, we performed immunohistochemistry in 
the brainstem sections subsequently. For immunohistochemical 
staining of the brainstem, sections with thickness of 5 μm were 
serially cut in the upper and lower parts of the midbrain, and the 
upper, middle, and lower parts of the pons, and medulla oblongata. 
They were deparaffinized, quenched with 1% hydrogen peroxide, 
and treated after microwave antigen retrieval with the following 
antibodies: mouse monoclonal antibodies to glial fibrillary acidic 
protein (GFAP, Dako, Glostrup, Denmark), tyrosine hydroxylase 
(Affinity Bioreagents, Inc., Golden, CO, USA), and tryptophan 
hydroxylase (Oncogen Research Product, Cambridge, MA, 
USA), in addition to rabbit polyclonal antibodies to substance P 
(Zymed Laboratories, Foster City, CA, USA), methionine-
enkephalin (Chemikon International, Inc., Temecula, CA, USA), 
and c-fos (Santa Cruz Biotechnology, CA, USA) at the following 
concentrations: 1:50 (GFAP, substance P), 1:100 (tryptophan 
hydroxylase), 1:400 (tyrosine hydroxylase), 1:1000 (methionine-
enkephalin, c-fos). Antibody binding was visualized by means 
of the avidin–biotin–immunoperoxidase complex method 
(Nichirei, Tokyo, Japan) following the manufacturer’s protocol. 
No staining was confirmed in sections in the absence of either 
antibody. In immunohistochemistry for tyrosine hydroxylase and 
tryptophan hydroxylase, counts of immunoreactive neurons were 
performed by the manual-labeling of appropriate cells with nuclei 
in two serial sections, and the mean value were calculated in each 
brainstem region (Table 2). The mean and SD of averages in the 
controls and SUD cases was analyzed with t-test for the com-
parison, and reported p values were shown in Table 2. This study 
was approved by the Ethical Committee in Tokyo Metropolitan 
Institute of Medical Science.
resUlTs
A mild increase of the goblet cells was found in the SUD cases 
(Table 1), but that may be related to recurrent subtle aspiration, 
and did not lead to the diagnosis of bronchopneumonia. Neither 
FigUre 1 | representative photographs in immunohistochemistry for 
tyrosine hydroxylase. Immunoreactivity for tyrosine hydroxylase was 
observed in the neurons and neuronal processes in the periaqueductal gray 
matter in the control 5 (a). The SUD case 6 showed a reduction in neurons 
and processes immunoreactive for tyrosine hydroxylase in the same area (B). 
Bars = 80 μm.
TaBle 2 | summary of immunohistochemistry for tyrosine hydroxylase and tryptophan hydroxylase.
no. Tyrosine hydroxylase Tryptophan hydroxylase
Periaqueductal  
gray matter
locus ceruleus Dorsal vagal nucleus superior central  
nucleus
Medullary raphe 
nucleus
left right left right
controls
1 28 124.5 124.5 17.5 17 nd 34.5
2 19 88.5 91 6.5 7 170.5 49.5
3 10 nd nd 10 12.5 nd 35.5
4 13.5 144.5 132.5 11 13.5 165 37
5 35 124 151 10.5 11.5 52 31
6 26.5 147 127 12 10 94.5 12.5
7 23.5 116.5 51 9 9.5 141 20.5
mean ± SD 22 ± 9 124 ± 21 113 ± 36 11 ± 3 12 ± 3 125 ± 50 32 ± 12
sudden unexplained death
1 34 94 88.5 11.5 13 164 59
2 7.5 23 24.5 0 0 110 28
3 28 136.5 136.5 7 8 80 13
4 35.5 98 114 10 13 67.5 56.5
5 29 137.5 138 12 14.5 119 13
6 5.5 17 15.5 0 0 53.5 4.5
7 25.5 76 73.5 7.5 11 55 47.5
8 17 85 79.5 19.5 18 93 16
mean ± SD 23 ± 12 83 ± 45 84 ± 46 8 ± 6 10 ± 7 93 ± 37 30 ± 22
p value (t-test) 0.92 0.06 0.23 0.38 0.51 0.22 0.85
The number of tyrosine hydroxylase- and tryptophan hydroxylase-immunoreactive neurons in the each brainstem region is expressed. The mean of averages in controls and the 
SUD cases was analyzed with t-test for the comparison, and reported p values were shown in Table 2. Hatched labeling with bold characters denotes a reduction in the number of 
neurons less than the mean minus 2SD of average in controls.
nd, not determined.
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neuronal loss nor increase of astrocytes immunoreactive for 
GFAP was observed in the brainstem regions examined in the 
SUD cases, in comparison with sections in controls. Neurons 
and neuronal processes immunoreactive for tyrosine hydroxylase 
were observed in the periaqueductal gray matter in the midbrain, 
locus ceruleus, and dorsal vagal nucleus in controls (Table  2; 
Figure 1A). Neurons immunoreactive for tryptophan hydroxy-
lase were found in the superior central nucleus and raphe nucleus 
in the medulla oblongata in controls (Table 2). There was no sig-
nificant difference in the number of neurons immunoreactive for 
either tyrosine hydroxylase or tryptophan hydroxylase between 
controls and the SUD cases. However, the SUD cases 2 and 6 
exhibited a reduction in the number of neurons immunoreactive 
for tyrosine and/or tryptophan hydroxylase less than the mean 
minus 2SD of average in the controls (Table 2; Figure 1B). There 
was a variation in the degree of immunoreactivity for substance P 
and methionine-enkephalin in the neuropil and neuronal fib-
ers in the substantia nigra in both controls and the SUD cases. 
Immunoreactivity for substance P was augmented in seven of 
eight SUD cases in the spinal tract nucleus of trigeminal nerve, 
in comparison with that in controls (Table  3; Figure  2). Four 
of the aforementioned seven SUD cases showed the increased 
immunoreactivity for substance P in the dorsal vagal nucleus. 
Moreover, the four of seven SUD cases with the augmented 
immunoreactivity for substance P also demonstrated increased 
immunoreactivity for methionine-enkephalin in the spinal tract 
nucleus of trigeminal nerve (Table 3). There were a few neurons 
immunoreactive for c-fos in the periaqueductal gray matter, 
pontine tegmentum, and posterior funicular nucleus in both 
controls and the SUD cases (Table 4). In the hypoglossal nucleus, 
neurons immunoreactive for c-fos were found in six of eight SUD 
cases, but not in controls (Figures 3A,B). In addition, five of the 
aforementioned SUD cases and the SUD case 1 showed neurons 
immunoreactive for c-fos in the dorsal vagal nucleus, in which 
those were observed only in the control 4 (Figures 3C,D).
DiscUssiOn
In the SIDS victims, fine morphological changes have been noted 
in the brainstem respiratory network, including Kölliker–Fuse 
FigUre 3 | representative photographs in immunohistochemistry for 
c-Fos. In the hypoglossal nucleus, there were no neurons immunoreactive 
for c-fos in the control 5 (a), which was found in the SUD cases 5 (B). 
Neurons immunoreactive for c-fos were observed in the dorsal vagal nucleus 
in both the control 4 (c) and SUD case 4 (D). Bars = 20 μm.
TaBle 4 | summary of immunohistochemistry for c-fos.
no. Periaqueductal  
gray matter
Pontine 
tegmentum
Posterior 
funicilar 
nucleus
hypoglossal 
nucleus
Dorsal 
vagal 
nucleus
controls
1 1+ (−) (−) (−) (−)
2 (−) 1+ (−) (−) (−)
3 1+ 1+ (−) (−) (−)
4 1+ (−) 1+ (−) 1+
5 (−) (−) (−) (−) (−)
6 1+ 1+ (−) (−) (−)
7 1+ 1+ (−) (−) (−)
sudden unexplained death
1 1+ (−) (−) (−) 1+
2 (−) (−) (−) (−) (−)
3 1+ (−) (−) 1+ 1+
4 (−) (−) (−) 1+ 1+
5 (−) (−) (−) 1+ 1+
6 (−) (−) (−) 1+ (−)
7 (−) (−) 1+ 1+ 1+
8 1+ (−) (−) 1+ 1+
The absence and presence of neurons immunoreactive for c-fos are denoted as (−) 
and 1+.
FigUre 2 | representative photographs in immunohistochemistry for 
substance P. Immunoreactivity for substance P was observed in a few 
neuronal processes in the spinal tract nucleus of trigeminal nerve in the 
control 1 (a), while that was found in many neuronal processes in the SUD 
case 2 (B). Bars = 40 μm.
TaBle 3 | summary of immunohistochemistry for substance P and 
methionine-enkephalin.
no. substance P Methionine-enkephalin
substantia 
nigra
Dorsal 
vagal 
nucleus
spinal  
tract  
nucleus 
of trigeminal 
nerve
substantia 
nigra
Dorsal 
vagal 
nucleus
spinal 
tract 
nucleus of 
trigeminal 
nerve
controls
1 2+ 1+ 1+ 1+ (−) (−)
2 nd 1+ 1+ nd 1+ (−)
3 2+ 1+ 1+ 1+ 1+ (−)
4 1+ 1+ 1+ 1+ 1+ 1+
5 2+ 1+ 1+ 2+ 1+ 1+
6 1+ 1+ 1+ 1+ 1+ 1+
7 2+ 1+ 1+ 2+ 1+ 1+
sudden unexplained death
1 2+ 1+ 1+ 2+ 1+ (−)
2 2+ 1+ 2+ 1+ 1+ (−)
3 2+ 2+ 2+ 1+ 1+ 1+
4 1+ 2+ 2+ 1+ 1+ 1+
5 2+ 2+ 2+ 2+ 1+ 2+
6 2+ 1+ 2+ 1+ 1+ 2+
7 1+ 1+ 2+ 1+ 1+ 2+
8 2+ 2+ 2+ 2+ 1+ 2+
The degree of immunoreactivity of neuronal processes was graded as follows: absence 
as (−); a few as 1+; and many as 2+. Hatched labeling with bold characters denotes 
an augmentation of immunoreactivity compared with that in controls.
nd, not determined.
4
Hayashi and Sakuma Sudden Unexplained Death in Patients with SMID
Frontiers in Neurology | www.frontiersin.org June 2016 | Volume 7 | Article 93
nucleus (7–9), although autopsy failed to reveal coarse lesions in 
the brain. Similarly, the disturbances in the autonomic nervous 
system, fluctuating muscle tone with involuntary movements 
and/or hypersensitivity to environmental stimuli, may be 
involved in SUD in patients with neurological disorders (12), 
but the detailed pathogenesis still remains to be investigated. We 
previously reported the selective disturbance in the brainstem 
expressions of tyrosine hydroxylase, tryptophan hydroxylase, 
and methionine-enkephalin in autopsy cases of West and 
Lennox–Gastaut syndromes (15). In this analysis, the expressions 
of neurotransmitters, substance P, methionine-enkephalin, and 
c-fos were examined in serial brainstem sections in the SUD 
cases, focusing on the brainstem dysfunction. The SUD cases 
2 and 6 seemed to show disturbances in catecholamine and 
serotonin neurons (Table 2). In addition, seven of the SUD cases 
including the cases 2 and 6 showed increased immunoreactiv-
ity for substance P and/or methionine-enkephalin in the spinal 
tract nucleus of trigeminal nerve (Table  3). Seven of the eight 
SUD cases demonstrated neurons immunoreactive for c-fos in 
the hypoglossal nucleus and/or dorsal vagal nucleus (Table 4). 
These immunohistochemical abnormalities lacked both obvious 
neuronal loss and gliosis, suggesting the possible disturbances of 
brainstem function.
Sudden infant death syndrome victims were reported to 
show reduced immunoreactivity for tyrosine hydroxylase in 
5Hayashi and Sakuma Sudden Unexplained Death in Patients with SMID
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the dorsal vagal nucleus and ventrolateral reticular formation 
in the medulla oblongata (10). Sudden death sometimes occurs 
in patients with FCMD, in which the neurons immunoreactive 
for tyrosine hydroxylase were reduced in the reticular formation 
of medulla oblongata, dorsal vagal nucleus, and solitary tract 
nucleus (11, 12). Tyrosine hydroxylase is a rate-limiting enzyme 
in catecholamine biosynthesis, and the reduced expression of 
tyrosine hydroxylase in the brainstem are assumed to reflect the 
dysfunction of catecholamine neuron system, which can lead 
to disturbed autonomic regulation and/or neural respiratory 
control. The similar pathological processes can be speculated in 
the SUD cases 2 and 6 in this analysis. The medullary serotonin 
neurons, which are also involved in the autonomic and respira-
tory homeostasis, showed increased cell density with reduced 
binding receptor sites in SIDS victims (16). The SUD case 6 
only showed a reduction of medullary serotonin neurons, and 
the lesion of serotonin neurons in the SUD cases seems to be 
less predominant and different from that in SIDS. Increased 
immunoreactivity for substance P associated with proliferation 
of astrocytes was found in the pontine reticular formation and 
the medullary spinal trigeminal nucleus in the SIDS victims (10). 
Inasmuch as substance P increases central inspiratory activity 
and can mediate the central nervous response to hypoxia, it is 
speculated that the augmented expression of substance P in the 
SIDS victims may be related to the influence of hypoxia. The 
augmented immunoreactivity for substance P was also observed 
in the spinal tract nucleus of trigeminal nerve and dorsal vagal 
nucleus in the SUD cases, but astrocytes immunoreactive for 
GFAP were not increased. In our previous study, the immu-
noreactivity for methionine-enkephalin, but not substance P, 
was reduced in the absence of neuronal loss and gliosis in the 
spinal tract nucleus of trigeminal nerve in the autopsy cases 
of West and Lennox–Gastaut syndromes (15). Although the 
exact mechanism of difference in the disturbed expressions of 
substance P and methionine-enkephalin between intractable 
epilepsy and SUD is not clear, it is suggested that the impair-
ments of trigeminal system can be involved. C-fos is the first 
gene activated by noxious signals, particularly in the presence 
of hypoxia, and useful to demonstrate the stimulus-related local 
neuronal activation (13, 14). Neurons immunoreactive for c-fos 
were increased in the dorsal vagal nucleus in SIDS victims (13), 
and those were observed in the hypoglossal nucleus and/or the 
dorsal vagal nucleus in the SUD cases in this analysis. Since the 
hypoglossal nucleus and dorsal vagal nucleus are known to be 
associated with neuronal cardiopulmonary regulation (17), the 
increase of neurons immunoreactive for c-fos in SIDS victims 
and the SUD cases may reflect a certain response to hypoxic 
brain insults.
It is controversial whether the immunohistochemical changes 
in this analysis are causes or results of SUD; however, the data sug-
gest the possible involvement of brainstem dysfunction in SUD. 
Patients with SMID occasionally demonstrate abnormalities in 
both the sleep parameters in all-night polysomnography and the 
R2 components in blink reflex, which are related to the brainstem 
catecholamine neurons and the spinal tract nucleus of trigeminal 
nerve, respectively, both of which demonstrated changes in the 
SUD cases of SMID in this analysis (18). We believe that routine 
neurophysiological evaluation of brainstem functions, including 
all-night polysomnography and blink reflex, will give us a clue to 
prevent SUD in patients with SMID. Furthermore, we will try to 
quantify the protein expressions by Western blot analysis in the 
frozen specimen of autopsy brains in the future.
cOnclUsiOn
Sudden unexplained death remains to be one of the important 
causes of death in patients with SMID, although the exact patho-
mechanisms are not clarified fully. The data in this analysis sug-
gest the possible involvement of brainstem dysfunction in SUD, 
and the detailed neurophysiological evaluation of brainstem 
functions is recommended in patients with SMID.
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